Boris Royak
Psychiatry · Beachwood, OHNPI 1528091899
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,032 of the $61,902 with a category attached, or 64.7%. 20 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 57.2% of the total. Reporting peaked in 2019 at $35,156 and has fallen 99.4% since, to $228 in 2025. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $276.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$35K
- Acadia Pharmaceuticals Inc$21K
- Indivior Inc.$2K
- Johnson & Johnson$1K
- Sunovion Pharmaceuticals Inc.$475
- AbbVie$392
- plus $1K from 14 others
What the payments were for
- Consulting fees$14,60024%
- Speaking & faculty fees$40,03265%
- Travel & lodging$2,6334%
- Food & beverage$4,6367%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 45 | $35,408 |
| Acadia Pharmaceuticals Inc | 41 | $20,627 |
| Indivior Inc. | 4 | $2,466 |
| Johnson & Johnson | 13 | $1,334 |
| Sunovion Pharmaceuticals Inc. | 25 | $475 |
| AbbVie(2 entities) | 32 | $392 |
| Otsuka America Pharmaceutical, Inc. | 17 | $291 |
| Lundbeck LLC | 11 | $204 |
| Alkermes, Inc. | 10 | $193 |
| Vanda Pharmaceuticals Inc. | 9 | $175 |
| Jazz Pharmaceuticals Inc. | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Corium, LLC | 1 | $34 |
| Neos Therapeutics, LP | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Shire North American Group Inc | 1 | $18 |
| Neuronetics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,902 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 27 | $587 |
| Oxcarbazepine | 12 | $349 |
| Benztropine Mesylate | 13 | $266 |
| Mirtazapine | 15 | $206 |
| Sertraline Hcl | 13 | $199 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Beachwood
- Amit MohanBeachwood$236K
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
- Paul KeckCincinnati$739K
- Ali MelhemSteubenville$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.